Background and aims: Evaluating the impact of coronary revascularization on patients' health related quality of life with a patient-based and disease-specific tool is important for drawing conclusions about treatment and outcomes. This study reports on the translation, adaptation and psychometric evaluation of a Greek version of the Coronary Revascularization Outcome Questionnaire (CROQ-Gr). Methods: A total of 609 (81.7% male) patients who had undergone coronary revascularization (percutaneous coronary intervention or coronary artery bypass grafting) were recruited from four hospitals in Athens. After translating the CROQ into Greek, a preliminary qualitative study and a pilot quantitative study were conducted. A full psychometric evaluation was carried out on the main study's data.
Introduction
Cardiovascular disease is one of the leading causes of mortality globally accounting for approximately 17 million deaths annually. 1 With respect to medical treatment, invasive and surgical coronary procedures have been developed and are widely used for treating coronary heart disease (CHD). The two most commonly used types of coronary revascularization are percutaneous coronary interventions (PCIs), formerly called percutaneous transluminal coronary angioplasty (PTCA) and generally known as stent placement, and coronary artery bypass grafting (CABG), generally known as bypass surgery. According to research evidence, these two procedures have reduced the mortality and morbidity rates of patients with coronary diseases. 2 However, health is not just a biomedical issue. Beyond the survival benefit and relief of symptoms, patients'
health-related quality of life (HRQoL) should be considered. 3 While there is no consensus definition of HRQoL, the most commonly adopted is that of the World Health Organization, which incorporates physical, psychological and social well-being. 4 The literature on quality of life demonstrates that monitoring the impact of an intervention on patients' HRQoL allows health professionals to enhance and promote patients' wellbeing, 5 to draw valid conclusions about the effectiveness of a specific treatment, to aid clinical decision making about the type of treatment that best suits individual needs, 6 to clarify issues requiring further research such as highlighting additional factors (e.g. duration of hospital stay after revascularization) that may influence outcome in the short and long term and, finally, to develop specific (tailored) interventions for enhancing patients' wellbeing. 7 Therefore, a great deal of research has been carried out using patient-based instruments in order to determine the level of patients' HRQoL before and after cardiac surgery. 8 However, no clear conclusions can be drawn because the literature provides inconsistent results. 9 The discrepancy in the literature can be partially explained by disagreement regarding the domains of HRQoL that patient-based instruments should measure and also by the use of generic instead of disease-specific instruments that assess patients' perception of health status.
Until recently, there were no validated disease-specific patient-based instruments for coronary revascularization. 10 Schroter and Lamping 11 therefore developed the Coronary Revascularization Outcome Questionnaire (CROQ). The use of this disease-specific measure might provide further and more accurate knowledge regarding the impact of coronary revascularization on patients' wellbeing. The CROQ 11 was developed to evaluate HRQoL and health outcomes before and after the two common operational coronary procedures, PCI and CABG, capturing aspects of recovery not addressed in other heart disease questionnaires.
The CROQ has four versions, a pre-and (three-month) post-revascularization version for each of the PCI and CABG treatments. The two pre-revascularization versions measure four domains containing 32 core evaluative items and one descriptive item that it is not taken into account in scale scores. Specifically these domains are symptoms, physical functioning, psychosocial functioning and cognitive functioning. The two post-revascularization versions include the same four domains plus two additional domains, satisfaction with outcome and adverse effects as well as two items that do not contribute to subscale scores.
Research demonstrates that the CROQ is valid and reliable in the original English version 11 as well as in its Italian, 10 Persian 12 and Japanese versions. 13 The literature suggests that the CROQ is a promising instrument for measuring HRQoL and health outcomes as it is the only tool that includes psychosocial and cognitive functioning as well as surgery-specific items. 14 In fact, the CROQ has been used to detect the effect of treatment in the short and long term 11 as it is more responsive than other instruments 15 and yields a greater response rate compared with other measures. 16 Studies using the CROQ suggest moderate to high effect sizes (d ⩾ 0.67) of coronary revascularization on HRQoL domains with the exception of cognitive functioning, where a small effect was found. 11 Moreover, the CROQ has been used in exploring HRQoL across various subtypes of coronary revascularization. 17, 18 For example, Angelini et al. 18 found no differences in patients' well-being between those treated with on-or off-pump CABG surgery. Similarly, Rogers et al. 17 found no difference in patients' HRQoL between those treated via left anterolateral thoracotomy (ThoraCAB) or via a conventional median sternotomy. 17 These findings are very important, especially where the cognitive subdomain is concerned. Previous literature suggests that patients undergoing off-pump CABG score higher in the cognitive subdomain compared with patients undergoing conventional CABG, 18 whereas the CROQ was able to detect accurately the lack of cognitive differences after one or other treatment, a finding that is supported by recent systematic reviews where authors have focused on studies using specialized methods of cognitive testing. 19, 20 Clearly the CROQ is an essential patient-based measure of disease-specific HRQoL. The aim of this study is to develop a psychometrically sound Greek version of the CROQ, the CROQ-Gr.
Method

Sample and data collection
After obtaining the approval of the relevant institutional ethics committees (at the University of Hertfordshire and of the four participating hospitals), patients were recruited from Tzaneio, Thriasio, Attiko and Metropolitan Hospitals between April 2009 and July 2012. Patients expected to undergo PCI or CABG in allied hospitals during the research period were eligible to participate in the study. Exclusion criteria were patients being below 18 years of age and patients with an emergency admission.
Measures
The CROQ consists of four versions: one pre-PCI, one post-PCI, one pre-CABG and one post-CABG. The two pre-operation versions are identical for the two procedures and capture four domains containing 32 core evaluative items (symptoms (seven items), physical functioning (eight items), psychosocial functioning (14 items) and cognitive functioning (three items)) and one descriptive item that is not taken into account in computing scale scores. The two post-operation versions consist of the same four subscales as the pre-operation version as well as three items that are not taken account of in computing scale scores and two additional domains in the post-operation versions: adverse effects (six items) and satisfaction with outcome (six items for the PCI version and 11 for the CABG version). Total scores are rated on a 0-100 scale. Higher scores indicate higher HRQoL level.
In addition to the CROQ-Gr, the Greek version of SF-36v2 TM Health Survey (SF-36) [21] [22] [23] questionnaire was used to test for construct validity. The SF-36 consists of 36 questions focusing on eight areas: physical functioning (PF, 10 items); role limitations due to physical health problems (RP, four items); bodily pain (BP, two items); general health perceptions (GH, five items); vitality tapping energy levels and fatigue (VT, four items); social functioning (SF, two items), role limitations due to emotional problems (RE, three items); and mental health (MH, five items). The average score of PF, GH, RP, BP are used to create the physical components summary (PCS) while VT, SF, RE, MH are used to create the mental components summary (MCS). Higher scores indicate higher HRQoL level. Total scores are rated on a 0-100 scale. Higher scores indicate higher HRQoL level.
Translation and adaptation
An instrument that is validated and widely used in one culture is not necessarily valid and reliable in every language and culture and its adaptation requires more than a simple literal translation. However, while at least 17 methods of adaptation can be identified, 24 the majority agree upon a multi-stage procedure. It involves at least two forward translators, one or two back translators, a synthesis of findings, a review by an expert panel, pre-testing and a formal psychometric testing. 24 The approach adopted here is that of the International Quality of Life Assessment (IQOLA) [25] [26] [27] [28] [29] [30] [31] [32] since this is the approach followed for the cultural adaptation of the SF-36, which is the mostly adapted instrument of HRQoL globally.
After the forward translation, a scientific panel consisting of the principal investigators and a bilingual individual revised the preliminary version of the CROQ-Gr. In addition, 25 qualitative interviews (10 with patients who had undergone PCI and 15 with patients who had undergone CABG) were conducted to ensure content validity, clarity, appropriateness of wording, questionnaire format and instructions and feasibility (regarding respondent burden). After minor modifications, the final translation back to English was conducted by another bilingual individual. Furthermore, a pilot study was conducted to demonstrate acceptability and reliability with a total of 112 Greek patients who had undergone PCI (data not shown).
Statistical analysis
Analyses are presented as suggested by the original CROQ's developers 11 and, for comparison with the original, their terminology is used. First, descriptive analysis was carried out to estimate acceptability and item variance. Reliability analysis was performed using Cronbach's alpha to estimate internal consistency and intraclass correlation coefficients (ICCs) to estimate test-retest reliability (test-retest was carried out in a subsample of 20 PCI and 20 CABG patients completing measures at baseline and three weeks later). Construct validity (within scale) was assessed using principal axis factoring extraction, as per the development of the original CROQ, using the three-month post-coronary revascularization data. A four-factor solution was expected and, with Varimax rotation, was set a priori with coefficient suppression at 0.35. Construct validity (against external criteria) was evaluated using Spearman's rho correlations between the CROQ-Gr and SF-36 for 45-52 patients for each of the procedures at baseline and at three months postcoronary revascularization. It was expected that physical functioning/symptoms scales of the CROQ-Gr would correlate more strongly with the PCS of the SF-36 than with the MCS and that the psychological functioning scale of the CROQ-Gr would correlate more strongly with the MCS of the SF-36 than with the PCS. No predictions were made as to the association between the cognitive functioning scale of the CROQ and the SF-36. The scoring of the SF-36 was carried out with the use of the Health Outcomes Scoring Software 3.0. Data were analysed using SPSS version 20.0.
Results
Following the translation/adaptation and pilot testing of the CROQ-Gr (described in the Methods section), 472 Greek patients undergoing coronary revascularization (307 PCI and 165 CABG) were recruited for the extended psychometric evaluation of all four versions (i.e. the pre-and postversions for PCI and CABG). Of these, 76.01% (N=359) were men and mean age was M=60.4 years, SD=10.8.
Acceptability and reliability (internal consistency and test-retest)
Most of the CROQ-Gr versions have good acceptability with little missing data. Both Cronbach's alpha and ICCs exceeded the criterion of .70 for all scales, demonstrating excellent internal consistency and test-retest reliability (Table 1) .
Content validity
Content validity was evaluated during the development of the CROQ-Gr versions and in the preliminary translation/ adaptation and pilot studies described above (which included a panel of experts as well as face-to-face interviews with patients).
Construct validity (within scale)
In addition to the high levels of internal consistency and intraclass correlation coefficients described above, support for the construct validity of the CROQ-Gr can be demonstrated from the findings of the factor analysis. For all versions, the Kaiser-Meyer-Olkin test verified sampling adequacy (KMO; >.78) and Bartlett's test confirmed sphericity (p<.001). Four factors had Eigen values greater than 1 and items loaded on their expected factor ( Table 2) . The four factor model of rotated squared loadings explained between 41.7% and 50.3% of the variance, depending on the version. Results were almost identical to the original English version.
Construct validity (against external criteria)
Construct validity against external criteria was examined through the correlations between the CROQ-Gr and the SF-36 subscales (see Table 3 ). As expected, the symptoms and physical functioning subscales of the CROQ-Gr correlated more strongly with the PCS of the SF-36 than with the MCS. Conversely, the psychological functioning subscale of the CROQ-Gr correlated more strongly with the MCS of the SF-36 than with the PCS. These results were true for both procedures and for both the pre-and postprocedure versions, thus demonstrating both convergent and divergent validity. The cognitive functioning subscale of the CROQ-Gr was not reliably related to any subscales of the SF-36.
Discussion
Following forward and back translation, interviews with patients, pilot testing and, following modifications, a full psychometric evaluation of the CROQ, the Greek version of the CROQ was shown to be a practical and psychometrically sound measure of HRQoL and other health issues before and after heart revascularization. It is acceptable to patients and can be used in relation to both PCI and CABG. These findings are in accordance with findings reported by the English, 11 Italian, 10 Persian 12 and Japanese 13 versions of the CROQ.
Due to the current lack of a Greek disease-specific measure of HRQoL and health outcomes after coronary revascularization, it could be argued that the development of the CROQ-Gr is essential. It is a subjective measure that enables assessment of both therapeutic procedures from the patient's point of view that, in turn, could allow greater insight concerning patients' treatment and greater confidence in decision making about the type of treatment that best meets patients' needs. Reviewers 33 suggest that, in order to draw clear conclusions about the effectiveness of coronary revascularization on patients' HRQoL, shape decision making and develop appropriate policy, a combination of both types of measures (generic and specific) should be used. The non-significant correlations between some of the subscales in the CROQ-Gr and SF-36 suggests that there may indeed be aspects of quality of life that are captured in each measure that are not captured by the other; to determine the complete picture may, therefore, require the application of both. Furthermore, when interpreting the findings, cultural issues 34 should be considered, because they could influence the total scores observed for each subscale, which, in turn, could influence the conclusion about research findings. Specifically, scores obtained by the CROQ-Gr in the present study indicate that Greek patients report greater levels of HRQoL compared with English patients. 11 This may underline the presence of differences in patients' perceptions of wellbeing and thus scores may be culturally influenced. It may be the case that Greek patients perceive their HRQoL as 'good' despite their health issues. The literature indicates that patients in different cultures tend to selectively express symptoms as well as physical and/or psychological functioning in culturally acceptable ways. 28 Their reporting is based on the concept of how people perceive and articulate their physical and mental problems. For instance, individuals in one culture might perceive it to be more acceptable to suppress upsetting thoughts, while in other cultures individuals might be more likely to adopt a more active way of expressing and facing problems rather than ignoring them. In fact, many researchers examining cultural adaptations of measures share the same concern. 28 Thus, when researchers and clinicians interpret the literature they should bear in mind cultural issues as well. Differences in attitudes towards lifestyle factors could also be implicated. Research findings reveal that the vast majority of Greeks report low physical activity and tend to avoid exercising, walking or running, preferring a sedentary life, driving and using elevators, especially those living in urban areas. 35 Certainly this is consistent with the reports of some participants in the present study for whom items relating to walking 1km or using the stairs were not considered relevant and who therefore had difficulty completing this part of the CROQ-Gr. However, this is not a static phenomenon and health behaviours such as physical activity are increasing, perhaps as a result of public educational interventions for the 'therapeutic' role of physical activity that took place in Greece after its entry into the EU, particularly amongst younger women 36 and people with higher income. 37 The main limitations of the present study are the nonrandom sample, which diminishes claims for generalizability, the likelihood of social desirability bias due to the form of administration and the lack of clinical validation.
Future research could use the CROQ-Gr to address a number of issues. First, repeated assessment over time is important to track the trajectory of change within different domains. Second, identifying aspects of quality of life that are less likely to change following coronary revascularization is important in order to plan additional support. Third, the development of a shorter version would be useful for reducing respondent burden and increasing data quality, especially when research aims to explore many related issues (e.g. personality, mood) and thus may use many instruments.
Moreover, health professionals should be encouraged to use the CROQ-Gr for gaining a better understanding of the patient's experience, which may facilitate not only doctor-patient communication and treatment decisions, but also draw a clear conclusion about disease burden and effectiveness of rehabilitation.
Implications for practice
The CROQ can be used for:
• • Gaining a better understanding from the patients' point of view, which in turn will facilitate doctor-patient communication and promote the collaboration of doctor and patient in treatment decisions; • • Drawing a clear conclusion about patients' conditions and disease burdens; • • Measuring disease severity and making the decision of whether patients should be referred to interventional/surgery cardiologists for revascularization treatment; • • Assessing rehabilitation effectiveness;
• • Multicultural research. 
